Clinical Trial Update: Dose-Response Curve: Interventions to Prevent and Treat Radiodermatitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing dose-response interventions to prevent and treat radiodermatitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Radiodermatitis

Snippet

Sponsor: University of Brasilia | Conditions: Radiodermatitis | Phase 2 | Status: COMPLETED